Zum Inhalt

Do anti-TNF-α drugs increase cancer risk in rheumatoid arthritis patients?

  • 01.04.2013
  • Commentary
Erschienen in:

Abstract

Concern has been raised about an increased risk of lymphoma and skin cancers in patients with rheumatoid arthritis due to administration of anti-TNF-α drugs. Meta-analysis of observational data from registries as well as from randomized controlled trials has failed to show a significant increase in the risk of lymphoma when the sample size has been sufficiently large; skin cancer risk may represent a valid concern. Issues relating to interpretation of these data are discussed.
Titel
Do anti-TNF-α drugs increase cancer risk in rheumatoid arthritis patients?
Verfasst von
David A. Clark
Publikationsdatum
01.04.2013
Verlag
SP Birkhäuser Verlag Basel
Erschienen in
Inflammopharmacology / Ausgabe 2/2013
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608
DOI
https://doi.org/10.1007/s10787-012-0158-0
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.